Skip to main content
. 2017 Dec 22;7:18067. doi: 10.1038/s41598-017-18286-x

Figure 5.

Figure 5

Effect of pitavastatin-NPs on the homing of EPC in damaged blood vessels. (A) EPC group, (B) 0.01 μM pitavastatin-EPC; (C) 0.01 μM pitavastatin-NP-EPC, (D) 0.1 μM pitavastatin-EPC, and (E) 0.1 μM pitavastatin-NP-EPC (n = 3). (F) Histogram of the number of EPC exhibiting homing in each group. #P < 0.05 vs. EPC group, ##P < 0.01 vs. EPC group; &P < 0.05 vs. 0.1 μM pitavastatin-EPC group; NS = not significant.